About: T-HCA is a research topic. Over the lifetime, 3 publications have been published within this topic receiving 94 citations. The topic is also known as: trans-4-hydroxycrotonic acid & γ-hydroxycrotonic acid.
TL;DR: A comprehensive structure-affinity relationship study for novel ligands targeting these binding sites of GHB with high predictive validity is reported, which will be valuable in the further processes of both target characterization and ligand identification for the high-Affinity GHB binding sites.
Abstract: γ-hydroxybutyric acid (GHB) is a neuroactive substance with specific high-affinity binding sites. To facilitate target identification and ligand optimization, we herein report a comprehensive structure-affinity relationship study for novel ligands targeting these binding sites. A molecular hybridization strategy was used based on the conformationally restricted 3-hydroxycyclopent-1-enecarboxylic acid (HOCPCA) and the linear GHB analog, trans-4-hydroxycrotonic acid (T-HCA). In general, all structural modifications performed on HOCPCA led to reduced affinity. In contrast, introduction of diaromatic substituents into the 4-position of T-HCA led to high-affinity analogs (medium nanomolar Ki) for the GHB high-affinity binding sites as the most high-affinity analogs reported to date. The SAR data formed the basis for a 3-dimensional pharmacophore model for GHB ligands, which identified molecular features important for high-affinity binding, with high predictive validity. These findings will be valuable in the f...
TL;DR: Trans 4-hydroxycrotonic acid has been tritiated at the 2,3 positions, using a multi-step synthesis and a one-pot reaction for the three last critical steps, and was obtained with a specific radioactivity of 45 Ci/mmole (1.66 TBq/mmoles) and a radiochemical purity of 97%.
Abstract: Trans 4-hydroxycrotonic acid (T-HCA) has been identified in central nervous system of mammalians as a naturally occuring substance, which may compete with 4-hydroxybutyric acid (GHB) for specific biological targets, such as high affinity binding sites, uptake systems and metabolism enzymes. T-HCA has been tritiated at the 2,3 positions, using a multi-step synthesis and a one-pot reaction for the three last critical steps. Thus, T-HCA-[2,3-3H] was obtained with a specific radioactivity of 45 Ci/mmole (1.66 TBq/mmole) and a radiochemical purity of 97%.